Results 131 to 140 of about 85,442 (265)

Nitrogen Abundances in Early-Type Be Stars

open access: yes, 2015
A sample of 26 Be stars from the Magnetism in Massive Stars (MiMeS) spectroscopic survey are analyzed for their photospheric nitrogen abundances in an effort to detect rotational mixing in the Be stars. Be stars are massive stars, between 3 and 20 times the mass of the Sun, that are surrounded by a thin, equatorial disk of gas that produces emission ...
openaire   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

open access: yesMolecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou   +12 more
wiley   +1 more source

The abundances of carbon and nitrogen in the atmospheres of classical Be stars. [PDF]

open access: yesAstrophys Space Sci
Peters GJ   +4 more
europepmc   +1 more source

Visual Spectrophotometry of Early-type Stars [PDF]

open access: yesMonthly Notices of the Royal Astronomical Society, 1974
J. Davis, R. J. Webb
openaire   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Parenteral neonatal priming followed by heterologous mucosal booster favors IgM<sup>+</sup> memory B cell induction over systemic plasma cell differentiation. [PDF]

open access: yesFront Immunol
Foroutan Pajoohian P   +7 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Upper Atmosphere Dynamics and Drivers of Volatiles Loss from Terrestrial-Type (Exo)Planets. [PDF]

open access: yesSpace Sci Rev
Kubyshkina D   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy